1. Home
  2. FIRY vs HURA Comparison

FIRY vs HURA Comparison

Compare FIRY & HURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FIRY

Firy Inc. Class A Common Stock

N/A

Current Price

$12.08

Market Cap

177.9M

Sector

Technology

ML Signal

N/A

Logo TuHURA Biosciences Inc.

HURA

TuHURA Biosciences Inc.

N/A

Current Price

$1.97

Market Cap

160.5M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
FIRY
HURA
Founded
2012
2009
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
177.9M
160.5M
IPO Year
2020
2010

Fundamental Metrics

Financial Performance
Metric
FIRY
HURA
Price
$12.08
$1.97
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
★ $8.04
AVG Volume (30 Days)
141.7K
★ 202.8K
Earning Date
11-05-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 47.93
EPS
N/A
★ N/A
Revenue
★ $104,496,000.00
N/A
Revenue This Year
$22.11
N/A
Revenue Next Year
$7.99
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 12.52
N/A
52 Week Low
$7.92
$0.41
52 Week High
$14.12
$3.43

Technical Indicators

Market Signals
Indicator
FIRY
HURA
Relative Strength Index (RSI) 58.73 44.11
Support Level $9.31 $1.96
Resistance Level $14.02 $2.23
Average True Range (ATR) 0.81 0.10
MACD 0.01 -0.01
Stochastic Oscillator 51.69 35.00

Price Performance

Historical Comparison
FIRY
HURA

About FIRY Firy Inc. Class A Common Stock

Firy Inc, formerly Skillz Inc is a two-sided mobile gaming platform that connects developers with competitive players. Its reportable segments are: the Skillz segment and the RZR segment. Skillz segment's highlights include Monetize Through Competitions, Player Matching, Cross-Platform Support, Comprehensive Analytics, and Focus on Game Development. Aarki is a performance marketing platform that enables advertisers to acquire, retain, and monetize users across mobile, connected television (CTV), and other digital channels. Some of the games available on its platform are Dominoes Gold, Blackout Bingo, 21 Blitz, and Solitaire Cube, among others. It generates the majority of its revenue from the Skillz segment. Geographically, the company derives its key revenue from the United States.

About HURA TuHURA Biosciences Inc.

TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.

Share on Social Networks: